专利检索 ap:("Progenics Pharmaceuticals, Inc." OR "Wyeth LLC (Formerly Known as Wyeth)") AND inv:"AL-SHAREFFI, Kadum A." 第 1 页

1.

发明公开
CRYSTAL FORM OF (R)-N-METHYLNALTREXONE BROMIDE AND USES THEREOF 审中-公开
标题翻译：（R）-N-甲基亚甲基四氢溴酸盐的晶体形式及其用途

公开(公告)号：EP3263571A1

公开(公告)日：2018-01-03

申请号：EP17172002.2

申请日：2008-03-28

申请人： Progenics Pharmaceuticals, Inc. , Wyeth LLC (Formerly Known as Wyeth)

发明人： SMOLENSKAYA, Valeriya, N , AL-SHAREFFI, Kadum A. , PEREZ, Julio , SHAH, Syed M. , BOYD, Thomas

IPC分类号： C07D489/04 , A61K31/439 , A61P43/00

摘要： The present invention provides a new form of (R)-N-methylnaltrexone bromide, and compositions thereof, useful as a peripheral mu opiod receptor antagonist.

摘要翻译： 本发明提供了一种新的（R）-N-甲基纳曲酮溴化物及其组合物，可用作外周多巴胺受体拮抗剂。

2.

发明授权
CRYSTAL FORM OF (R)-N-METHYLNALTREXONE BROMIDE AND USES THEREOF 有权

公开(公告)号：EP3263571B1

公开(公告)日：2019-11-13

申请号：EP17172002.2

申请日：2008-03-28

申请人： Progenics Pharmaceuticals, Inc. , Wyeth LLC (Formerly Known as Wyeth)

发明人： SMOLENSKAYA, Valeriya, N , AL-SHAREFFI, Kadum A. , PEREZ, Julio , SHAH, Syed M. , BOYD, Thomas

IPC分类号： C07D489/04 , A61K31/439 , A61P43/00